Skip to content

Enjamb Blog

Company

Enjamb is backed by Y Combinator

Y Combinator is backing Enjamb as we build domain-specific AI for the teams running drug programs.

by Enjamb Team

Innovation Spotlight

Latest Product
Announcements

Insights

Institutional memory, with every source still attached

Preserve the evidence, tradeoffs, analyses, and approvals behind a decision, not only the document that survived it.

by Enjamb Team

“Turn approved evidence, decisions, analyses, and operating knowledge into a shared capability every team can use, with the source still attached and the decision visible.”
Introducing Company Brain

Technical Deep Dives

All Posts

Bring Biopharma-Class AI Into Your Company

Request a demo